Article: Psychedelic Drugs – Easing the Regulatory Hurdles for Development
CANNANNEW REPORT
Congress recently introduced a bill that could expand access to therapeutic psychedelics that are designated as Breakthrough Therapies. These products are potentially useful in treating addiction, depression, post-traumatic stress disorder (PTSD), and other neurologic diseases. In recognition of the need to fulfill research and development requirements of certain Schedule I psychedelics, the Drug Enforcement Agency […]
Excerpt only …
READ MORE BELOW
Source : Article: Psychedelic Drugs – Easing the Regulatory Hurdles for Development
reposted by Cannabis News World
You must log in to post a comment.